Search Results 51-60 of 9712 for ishitani'

  1. TC215 International Organization for Standardization.

  2. Publications - Brendan C. Lanpher, M.D. - Mayo Clinic

    MacArthur TA, Ongie LJ, Lanpher BC, Ishitani MB. Pediatric manifestations of Lynch Syndrome: A single center experience. J Pediatr Surg Case Rep. 2022 Nov ...

  3. Mayo Clinic Hospital (Arizona) Interventional Radiology Residency BLOCK DIAGRAM TWO-YEAR RESIDENT (Resident has not completed ES

    MCH. Rotation. Name. Vasc IR Vasc IR Vasc IR. Vasc IR. Vasc IR. Vasc IR. Vasc IR. Vasc IR. Vasc IR Vasc I/U. Vasc. Surgery. Elective. % Outpt. 40.

  4. Keith M. Furutani, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Keith M. Furutani, Ph.D., studies emerging technologies in radiation therapy, especially carbon ion radiation therapy.

  5. Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device - Mayo Clinic

    The HeartMate PHP System is a temporary (<6 hours) ventricular assist device indicated for use during high risk percutaneous coronary interventions (PCI) ...

  6. Publications

    Publications. Mukhtar H, Iyer V, Demirel N, Bendel EC, Bjarnason H, Misra S. Embolotherapy for Pulmonary Arteriovenous Malformations in the Pediatric ...

  7. Transient Ischemic Attack Clinical Trials - Mayo Clinic Research

    An ischemic stroke is a cerebral infarction. In POINT, eligibility is limited to brain TIAs and to minor ischemic strokes (with an NIH Stroke Scale [NIHSS] ...

  8. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    Prior clinical experience with CD38-targeting antibodies, including daratumumab, establish this molecule as an important therapeutic target in multiple myeloma.

  9. ADJUSTING SIGNIFICANCE LMELS IN CENSORED DATA WHEN USING MULTIPLE TESTS SIMULTANEOUSLY by THOMAS R. FLE!YING and DAVID P. YARRIN

    I. Introduction. The last thirty years have seen a considerable increase in the amount of research literature in statistics.

  10. A Study to Evaluate the Effectiveness and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients - Mayo Clinic

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...